Form 4: Precigen CFO Granted 175,000 Restricted Stock Units

Precigen, Inc.'s Chief Financial Officer, Harry Thomasian Jr., was granted 175,000 Restricted Stock Units, which will vest over a period starting May 23, 2026.

Summary

• Harry Thomasian Jr., the Chief Financial Officer of Precigen, Inc. (PGEN), was granted 175,000 Restricted Stock Units (RSUs) on June 26, 2025.
• Each RSU represents a contingent right to receive one share of Precigen common stock.
• The RSUs are subject to a vesting schedule: 50% will vest on May 23, 2026, with the remaining portion vesting in equal monthly installments over the subsequent three years.
• Following this transaction, Mr. Thomasian directly beneficially owns 175,000 derivative securities (RSUs).

Sentiment

Score: 7

Explanation: The grant of Restricted Stock Units to a key executive like the CFO is generally viewed positively as it aligns management's interests with long-term shareholder value and aids in executive retention. It's a standard compensation practice.

Positives

• The grant of 175,000 Restricted Stock Units to the Chief Financial Officer aligns management's interests with long-term shareholder value.
• The multi-year vesting schedule encourages long-term retention and performance from a key executive.

Future Outlook

The vesting schedule for the granted Restricted Stock Units extends over three years following an initial vesting date, indicating a long-term incentive for the Chief Financial Officer.

Industry Context

This RSU grant is a standard form of executive compensation in the biotechnology and pharmaceutical industries, designed to align executive incentives with long-term company performance and shareholder value. It reflects a common practice for retaining key talent.

Comparison to Industry Standards

• The grant of Restricted Stock Units (RSUs) to a Chief Financial Officer is a common executive compensation practice across the biotechnology and broader corporate sectors.
• While specific grant sizes vary by company size, performance, and executive role, RSUs are widely used by companies like Amgen, Gilead Sciences, and Moderna to incentivize long-term performance and retention, aligning executive interests with shareholder value.
• The vesting schedule, with an initial cliff followed by monthly installments, is also a standard approach to ensure continued commitment.

Related Party Transactions

• Grant of 175,000 Restricted Stock Units to Harry Thomasian Jr., the Chief Financial Officer, as part of his compensation package.

Stakeholder Impact

• Shareholders: Potential long-term value creation through aligned executive incentives.
• Employees: May signal stability in executive leadership.

Next Steps

• Continued vesting of the Restricted Stock Units according to the specified schedule.

Key Dates

Keywords

Precigen, PGEN, Restricted Stock Units, RSU, Insider Transaction, SEC Form 4, Executive Compensation, Harry Thomasian Jr., Chief Financial Officer, Equity Grant